134 related articles for article (PubMed ID: 22796453)
1. Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists.
Faedo S; Perdonà E; Antolini M; di Fabio R; Merlo Pich E; Corsi M
Eur J Pharmacol; 2012 Oct; 692(1-3):1-9. PubMed ID: 22796453
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
Malherbe P; Borroni E; Pinard E; Wettstein JG; Knoflach F
Mol Pharmacol; 2009 Sep; 76(3):618-31. PubMed ID: 19542319
[TBL] [Abstract][Full Text] [Related]
3. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
4. Binding kinetics differentiates functional antagonism of orexin-2 receptor ligands.
Mould R; Brown J; Marshall FH; Langmead CJ
Br J Pharmacol; 2014 Jan; 171(2):351-63. PubMed ID: 23692283
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.
Langmead CJ; Jerman JC; Brough SJ; Scott C; Porter RA; Herdon HJ
Br J Pharmacol; 2004 Jan; 141(2):340-6. PubMed ID: 14691055
[TBL] [Abstract][Full Text] [Related]
6. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
Silveyra P; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras.
Putula J; Kukkonen JP
Neurosci Lett; 2012 Jan; 506(1):111-5. PubMed ID: 22079339
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomnia.
Winrow CJ; Gotter AL; Cox CD; Tannenbaum PL; Garson SL; Doran SM; Breslin MJ; Schreier JD; Fox SV; Harrell CM; Stevens J; Reiss DR; Cui D; Coleman PJ; Renger JJ
Neuropharmacology; 2012 Feb; 62(2):978-87. PubMed ID: 22019562
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
[TBL] [Abstract][Full Text] [Related]
10. SB-334867-A: the first selective orexin-1 receptor antagonist.
Smart D; Sabido-David C; Brough SJ; Jewitt F; Johns A; Porter RA; Jerman JC
Br J Pharmacol; 2001 Mar; 132(6):1179-82. PubMed ID: 11250867
[TBL] [Abstract][Full Text] [Related]
11. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
[TBL] [Abstract][Full Text] [Related]
12. Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Ward RJ; Pediani JD; Milligan G
Br J Pharmacol; 2011 Mar; 162(6):1439-52. PubMed ID: 21175569
[TBL] [Abstract][Full Text] [Related]
13. Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists.
McAtee LC; Sutton SW; Rudolph DA; Li X; Aluisio LE; Phuong VK; Dvorak CA; Lovenberg TW; Carruthers NI; Jones TK
Bioorg Med Chem Lett; 2004 Aug; 14(16):4225-9. PubMed ID: 15261275
[TBL] [Abstract][Full Text] [Related]
14. Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells.
Cataldi NI; Lux-Lantos VA; Libertun C
Regul Pept; 2012 Oct; 178(1-3):56-63. PubMed ID: 22749989
[TBL] [Abstract][Full Text] [Related]
15. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist.
Winrow CJ; Gotter AL; Cox CD; Doran SM; Tannenbaum PL; Breslin MJ; Garson SL; Fox SV; Harrell CM; Stevens J; Reiss DR; Cui D; Coleman PJ; Renger JJ
J Neurogenet; 2011 Mar; 25(1-2):52-61. PubMed ID: 21473737
[TBL] [Abstract][Full Text] [Related]
16. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
[TBL] [Abstract][Full Text] [Related]
17. Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.
Di Fabio R; Pellacani A; Faedo S; Roth A; Piccoli L; Gerrard P; Porter RA; Johnson CN; Thewlis K; Donati D; Stasi L; Spada S; Stemp G; Nash D; Branch C; Kindon L; Massagrande M; Poffe A; Braggio S; Chiarparin E; Marchioro C; Ratti E; Corsi M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5562-7. PubMed ID: 21831639
[TBL] [Abstract][Full Text] [Related]
18. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
[TBL] [Abstract][Full Text] [Related]
19. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors.
Mang GM; Dürst T; Bürki H; Imobersteg S; Abramowski D; Schuepbach E; Hoyer D; Fendt M; Gee CE
Sleep; 2012 Dec; 35(12):1625-35. PubMed ID: 23204605
[TBL] [Abstract][Full Text] [Related]
20. Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors.
Huang SC; Dai YW; Lee YH; Chiou LC; Hwang LL
J Pharmacol Exp Ther; 2010 Aug; 334(2):522-9. PubMed ID: 20494957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
